Achieve. Achieve. More Effective. Dialysis Treatment

Size: px
Start display at page:

Download "Achieve. Achieve. More Effective. Dialysis Treatment"

Transcription

1 Achieve More Effective Achieve Dialysis Treatment

2 The Crit-Line monitor measures the following: Real-time, lab-equivalent, non-invasive hematocrit (HCT) Real-time percent changes in intravascular blood volume Real-time, lab-equivalent, non-invasive oxygen saturation Gold Standard Accuracy The Crit-Line monitor hematocrit measurements are: Lab accurate Real-time (allows for immediate interventions) Continuous Non-invasive

3 Providing a Window into Your Patient s Bloodstream The Crit-Line monitor continuously measures a lab-equivalent hematocrit during a hemodialysis treatment without any blood sampling. BV Profile Screen Inverse Relationship Between Hematocrit and Percent Blood Volume Change These graphs are hypothetical and may not be representative of actual treatments. % BV CHANGE HCT = RCV BV x TIME (Hours) HCT By measuring the change in hematocrit during a treatment, the Crit-Line monitor is able to measure the percent change in a patient s intravascular blood volume. As HCT increases due to ultrafiltration, the blood volume decreases. As ultrafiltration progresses, blood volume decreases and HCT increases. Additional Crit-Line monitor benefits: Removes the maximum amount of fluid while preventing common symptoms of dialysis (e.g. nausea, cramping, vomiting). Provides a more effective treatment process for dialysis patients and clinicians. Peer-reviewed studies explain how the Crit-Line monitor has been used: The Controversies of Diagnosing and Treating Hypertension Among Hemodialysis Patients Rajiv Agarwal. Seminars in Dialysis. 25:4 pp July 2012 Hypervolemia Is Associated With Increased Mortality Among Hemodialysis Patients Rajiv Agarwal. Hypertension. 56:3 pp September 2010

4 Introduction of Dynamics in the Body Three Compartment Model Intracellular Interstitial Circulating Blood Volume Intra-vascular Dialysate Flow During dialysis, fluid is removed directly from the intravascular space through the ultrafiltration process. This space is then refilled with interstitial fluid from the extracellular space (the tissues). Prior to the introduction of the Crit-Line monitor, there were limited ways to measure how well the patient was tolerating the ultrafiltration rate that had been prescribed through dialysis therapy. The plasma refilling rate is the body s ability to shift fluid from the interstitial space into the intravascular space. With the Crit-Line monitor one can directly measure the percent of blood volume change in the intravascular space, and determine how well the body is refilling this compartment during dialysis. Window into your patient s blood stream Vascular space dynamics are key in fluid management Intracellular Interstitial Circulating Blood Volume Dialysate Flow The Crit-Line monitor permits a non-invasive focus on these dynamics

5 Interpreting the Crit-Line Display Each vertical line represents one hour of time the screen will re-scale if the treatment exceeds 4 hours BV Percent Change (displayed in increments of 5 %) Current HCT Value Current HgB Value (estimated) Time elapsed since beginning of treatment. The Event Marker (entered by user) is an arrow used to show when an intervention or symptom occurred. BV Percent Volume Change Graph Current BV Percent Change Value Current O2 Sat Value The Crit-Line monitor provides objective data and visual display of the Relative Blood Volume (RBV) slope as an indicator of volume status. Degree of Relative Blood Volume (RBV) slope Intradialytic plasma refill or inability to refill with ultrafiltration Intradialytic plasma refill with minimal ultrafiltration Relative Plasma Volume Relative Plasma Volume (RPV) slopes provide prognostic value to increase or decrease the rate of fluid removal in order to remove the maximum amount of fluid. (Hypertension. 2010; 55: ) An A profile illustrates that ultrafiltration and plasma refilling were equivalent during treatment.

6 A B profile, or gradual slope, has been targeted to find the best compromise between a high ultrafiltration rate and the prevention of intradialytic symptoms. The ideal slope is not a fixed percentage of BV decrease, and will vary from patient to patient. Typical published values seem to range from -1.33%/h to -8%/h depending on patient characteristics and algorithm. Published algorithm in chronic hemodialysis patients suggest a BV change of up to -8%/h in the first hour, with an additional BV change of <-4%/h in the following hours, up to a maximum total BV change of -16% at the end of a 3-4 hour dialysis. 1, 2, 3 Another study suggests a minimal average BV change of >-1.33%/h over four hours to be favorable. 4 All Crit-Line monitor parameters must be considered in conjunction with the patient s clinical assessment, comorbidities and existing medical history before prescribing or changing a dialysis treatment. Any decision regarding patient treatment is the sole responsibility of the attending physician. A C profile describes a dialysis session in which the patient is likely to experience some type of intradialytic morbidity such as lightheadedness, nausea, vomiting, cramping or hypotension; a condition often called crashing. This might occur at a BV change of >-8%/hr 1, 3, 5, 6 or at a total BV 1, 2, 3 change of -16% at the end of a 3 to 4 hr dialysis. Some patients may have a lower tolerance.

7 On-line HCT monitoring allows for the calculation of plasma volume changes and a comparison of the ultrafiltration and plasma refill rate. This may help identify patients prone to intradialytic hypotension. The mismatch in the ultrafiltration and plasma refill rates helps explain the physiology of hypotensive episodes. 5 The Reality of Dialysis Shortened Dialysis Time Crashing Aggressive Dialysis Poor Dialysis Adequacy Re-assess Target Weight Target Weight Not Achieved Overload Anti-Hypertensive Medications Key Findings from Recent Publications: Therapy guided by RPV slope may serve as a valid tool to better achieve target weight using augmented reduction therapy among hemodialysis patients. 4 RPV monitoring yields information that is prognostically important and independent of several risk factors including UF volume, aggressiveness of UF, and interdialytic ambulatory blood pressure. 6 RPV monitoring can assist in better achieving target weight. 7

8 References: 1. Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of Dry Weight by Monitoring Changes in Blood Volume During Hemodialysis using Crit-Line. Kidney Int. 68: , Goldstein S, Smith C, Currier H. Non-invasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis. J Am Soc Nephrol. 14: , Michael M, Brewer ED, Goldstein SL. Blood Volume Monitoring to Achieve Target Weight in Pediatric Hemodialysis Patients. Pediatr Nephrol. 19(4): , Sinha AD, Light RP, Agarwal R: Relative Plasma Volume Monitoring During Hemodialysis Aids the Assessment of Dry Weight. Hypertension. 55: , Schroeder KL, Sallustio JE, Ross EA. Continuous Haematocrit Monitoring During IntraDialytic Hypotension: Precipitous Decline in Plasma Refill Rates. NDT. 19: , Agarwal R. Hypervolemia Is Associated With Increased Mortality Among Hemodialysis Patients. Hypertension. 56: , Agarwal R, Alborzi P, Satayan S, Light RP. Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial. Hypertension. 53: , 2009 Fresenius Medical Care 920 Winter Street Waltham, MA The Crit-Line Monitor III (CLM III) is a non-invasive hematocrit, oxygen saturation and percent change in blood volume monitor used in the treatment of hemodialysis patients. In addition, the CLM III estimates access recirculation and access blood flow in hemodialysis patients. Caution: Federal (US) law restricts this device to sale by or on the order of a physician or other licensed practitioner. Read the Instructions for Use for safe and proper use of this device. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling Fresenius Medical Care North America. All rights reserved. Fresenius Medical Care, the triangle logo, and Crit-Line are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are property of their respective owners. P/N Rev A 01/2013

Crit-Line Monitor. Frequently Asked Questions

Crit-Line Monitor. Frequently Asked Questions Crit-Line Monitor Frequently Asked Questions Crit-Line Monitor Frequently Asked Questions 1 What is the indication for use of the Crit-Line monitor? The Crit-Line Monitor III is used to non-invasively

More information

Understanding Your Fluid Status During Dialysis and the Crit-Line. IV Monitor

Understanding Your Fluid Status During Dialysis and the Crit-Line. IV Monitor Understanding Your Fluid Status During Dialysis and the Crit-Line IV Monitor IV 1 Understanding Your Fluid Status During Hemodialysis Welcome to understanding your fluid status during hemodialysis. This

More information

Strategies to assess and manage hypervolemia The invisible threat in dialysis

Strategies to assess and manage hypervolemia The invisible threat in dialysis Strategies to assess and manage hypervolemia The invisible threat in dialysis Rajiv Agarwal MD Professor of Medicine, Indiana University School of Medicine Volume excess is common and costly. Admission

More information

Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line

Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line Kidney International, Vol. 68 (25), pp. 854 861 Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line HECTOR J. RODRIGUEZ,REGINA DOMENICI,ANNE DIROLL, and IRINA

More information

28-Feb-10 Reza Sabagh

28-Feb-10 Reza Sabagh DIALYSIS EQUIPMENTS (DIALYSIS MACHINE & R.O) Nursing Conference on Dialysis Tehran 1 The standard dialysis machines are designed for performing chronic and acute hemodialysis. They can be used in home

More information

Dialysis, personalized. More options for your patients well being.

Dialysis, personalized. More options for your patients well being. Dialysis, personalized. More options for your patients well being. Discover the advanced peritoneal dialysis (PD) system with improved features for added control and convenience during your patients treatment

More information

Although the adequacy of solute clearance in patients on

Although the adequacy of solute clearance in patients on Relative Plasma Volume Monitoring During Hemodialysis Aids the Assessment of Dry Weight Arjun D. Sinha, Robert P. Light, Rajiv Agarwal Downloaded from http://hyper.ahajournals.org/ by guest on May 2, 2018

More information

Ultrafiltration Programs : Clinical Experiences

Ultrafiltration Programs : Clinical Experiences Ultrafiltration Programs : Clinical Experiences By : Kay Woodruff, RN, BS, CNN, Divisional Clinical Specialist Lisa Miller Hedin, RN, CNN, Senior Clinical Specialist Introduction The purpose of this article

More information

Intradialytic hypertension is a marker of volume excess

Intradialytic hypertension is a marker of volume excess Nephrol Dial Transplant (2010) 1 of 6 doi: 10.1093/ndt/gfq210 NDT Advance Access published April 16, 2010 Original Article Intradialytic hypertension is a marker of volume excess Rajiv Agarwal 1,2 and

More information

Online HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys?

Online HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys? Online HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys? Patrice Ambühl Basics in SSN/SGN Meeting, December 4 2013 patrice.ambuehl@waid.zuerich.ch Nephrologie Therapeutical dilemma Ultrafiltra

More information

Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH))

Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH)) Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH)) By Dori Schatell, Medical Education Institute One of the main jobs of dialysis is to remove excess water from your body. Seems pretty

More information

02/28/2018. To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients

02/28/2018. To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients Lisa Koester Renal Nurse Practitioner Washington University School of Medicine St. Louis, MO To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients

More information

FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS

FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS Quality Insights Renal Network 3 October 2, 2014 Laura D. Byham-Gray, PhD, RD Professor & Director Master of Science in Clinical Nutrition Rutgers University

More information

Volume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher

Volume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher Volume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher Fluid balance in HD Weight HD HD HD Hypervolaemia DW Euvolaemia Hypovolaemia Mo Tu We Th Fr Sa Su Mo Chonic

More information

Supplemental Quick Reference Guide

Supplemental Quick Reference Guide Supplemental Quick Reference Guide How to use this Supplemental Quick Reference Guide This guide provides a 5-step method for considering a variety of frequencies and treatment lengths, based on achieving

More information

Hemocontrol. Management of Intradialytic Hypotension

Hemocontrol. Management of Intradialytic Hypotension Hemocontrol Management of Intradialytic Hypotension Dialysis Complications Cramps 31% Headache 18% Vomiting 1% Nephrologische Praxen Rostock 1998-1999 Dialysis n=6,508 Hypotension 50% BP = CO X SVR Potential

More information

Sodium ramping reduces hypotension and symptoms during haemodialysis

Sodium ramping reduces hypotension and symptoms during haemodialysis ORIGINAL ARTICLE Key words: Blood pressure; Hemodialysis solutions; Kidney failure, chronic; Renal dialysis; Sodium!!"#!"#$! HL Tang SH Wong KH Chu W Lee A Cheuk CMK Tang ILL Kong KS Fung WK Tsang HWH

More information

Nephrology Dialysis Transplantation

Nephrology Dialysis Transplantation Nephrol Dial Transplant (1996) 11 [Suppl 8]: 10-15 Nephrology Dialysis Transplantation Urea, sodium, and water changes in profiling dialysis H. Mann and S. Stiller ntroduction Control of osmolarity, as

More information

Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?

Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume? Nephrol Dial Transplant (2003) 18: 1353 1360 DOI: 10.1093/ndt/gfg171 Original Article Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume? Claudia Barth

More information

Striking the Optimal Balance in

Striking the Optimal Balance in Not Too fast, Not Too Slow: Striking the Optimal Balance in Hemodialysis Fluid Management ANNA/ IPRO Spring Symposium May 24, 2018 Jennifer E. Flythe, MD, MPH Assistant Professor of Medicine University

More information

UNIVERSITY OF CALGARY. Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of

UNIVERSITY OF CALGARY. Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of UNIVERSITY OF CALGARY Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of Intradialytic Hypotensive Episodes in Hemodialysis by Kelvin Cheuk-Wai Leung A THESIS SUBMITTED TO THE

More information

Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University

Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN

More information

Understanding Kt/V and Volume Control

Understanding Kt/V and Volume Control Understanding Kt/V and Volume Control Its practical use to determine dialysis and improve outcomes Caroline Williams RD May 23, 2017 Volume Control in Dialysis Patients Pathogenesis In the 1960s and early

More information

How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016

How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016 How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016 PD Dr. med. Andreas Kistler Leitender Arzt Nephrologie und Dialyse Kantonsspital Frauenfeld www.spital-thurgau.ch

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our

More information

Clinical Evaluation of an Oscillometric NIBP Technology During Hemodialysis According to the British Hypertension Society Protocol

Clinical Evaluation of an Oscillometric NIBP Technology During Hemodialysis According to the British Hypertension Society Protocol Clinical Evaluation of an Oscillometric NIBP Technology During Hemodialysis According to the British Hypertension Society Protocol Abstract Objectives Existing concerns over the accuracy of automated blood

More information

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome Quality ID #328 (NQF 1667): Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dl National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

Innovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018

Innovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018 Innovations in Cardio/Renal Patient Care Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018 Percent of Patients CVD = cardiovascular disease; ASHD =

More information

Making the Case For Less Invasive Flow Based Parameters: APCO + SVV. Patricia A. Meehan, RN, MS, CCRN (a) Education Consultant Edwards Lifesciences

Making the Case For Less Invasive Flow Based Parameters: APCO + SVV. Patricia A. Meehan, RN, MS, CCRN (a) Education Consultant Edwards Lifesciences Making the Case For Less Invasive Flow Based Parameters: APCO + SVV Patricia A. Meehan, RN, MS, CCRN (a) Education Consultant Edwards Lifesciences A New Gold Standard? How does the system work? Sensor

More information

Assessment and Management of Hypertension in Patients on Dialysis

Assessment and Management of Hypertension in Patients on Dialysis Assessment and Management of Hypertension in Patients on Dialysis Rajiv Agarwal,* Joseph Flynn, Velvie Pogue, Mahboob Rahman, Efrain Reisin, and Matthew R. Weir *Division of Nephrology, Department of Medicine,

More information

Mechanisms and Treatment of Intradialytic Hypertension

Mechanisms and Treatment of Intradialytic Hypertension Review Advances in CKD 2016 Published online: January 15, 2016 Peter Noel Van Buren a Jula K. Inrig b a University of Texas Southwestern Medical Center, Department of Internal Medicine and Division of

More information

ISSN: Volume 2 Number 7 (July-2014) pp

ISSN: Volume 2 Number 7 (July-2014) pp ISSN: 2347-325 Volume 2 Number 7 (July-204) pp. 25-22 www.ijcrar.com A study to evaluate the efficacy of RBV device (relative volume of blood) in hemodialysis patients and to determine the correlation

More information

THE INTRADIALYTIC BIOFEEDBACKS AND THE CARDIOVASCULAR STABILITY IN HYPOTENSION- PRONE PATIENTS Antonio Santoro, Bologna, Italy

THE INTRADIALYTIC BIOFEEDBACKS AND THE CARDIOVASCULAR STABILITY IN HYPOTENSION- PRONE PATIENTS Antonio Santoro, Bologna, Italy THE INTRADIALYTIC BIOFEEDBACKS AND THE CARDIOVASCULAR STABILITY IN HYPOTENSION- PRONE PATIENTS Antonio Santoro, Bologna, Italy Chair: Walter H. Hörl, Vienna, Austria Wojciech Zaluska, Lublin, Poland Prof.

More information

Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis?

Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis? ORIGINAL ARTICLE Korean J Intern Med 2017;32:117-124 Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis? In-Cheol Yoon, Hye-Min

More information

Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients

Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health San Antonio 2nd Annual Cardiorenal Connections Meeting, April 28,

More information

The goal of dialysis for patients with chronic renal failure is to

The goal of dialysis for patients with chronic renal failure is to Dialysate Composition in Hemodialysis and Peritoneal Dialysis Biff F. Palmer The goal of dialysis for patients with chronic renal failure is to restore the composition of the body s fluid environment toward

More information

University of Groningen

University of Groningen University of Groningen Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients Dasselaar, J.J.; Huisman, R.M.; De Jong, P.E.; Burgerhof, J.G.M.;

More information

Noninvasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis

Noninvasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis J Am Soc Nephrol 14: 2127 2131, 2003 Noninvasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis STUART L. GOLDSTEIN,* CAROLYN M. SMITH, and

More information

Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018

Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Objectives By the end of this session the learner will

More information

DEFINITIONS FOR FLUID STATUS & TARGET WEIGHT

DEFINITIONS FOR FLUID STATUS & TARGET WEIGHT Home Dialysis Interest Group HEALTHCARE TEAM TOOL DEFINITIONS FOR STATUS & TARGET WEIGHT BALANCED EXCESS DEFICIT Illustrations provided by: 1 BALANCE OF THE HOME HEMODIALYSIS PATIENT Dialysis Weight**

More information

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Methoxy polyethylene glycol-epoetin beta (Mircera) Reference Number: CP.CPA.322 Effective Date: 06.01.18 Last Review Date: 05.18 Line of Business: Commercial Coding Implications Revision

More information

Plasma sodium as a predictor of death and non-osmotic sodium storage

Plasma sodium as a predictor of death and non-osmotic sodium storage An update on sodium in CKD stage 5D Plasma sodium as a predictor of death and non-osmotic sodium storage Prof. Mustafa ARICI, MD Hacettepe University Faculty of Medicine Ankara-TURKEY 2 (new) questions...

More information

Fresenius Medical Care North America Corporate Headquarters Medical Department To: FMCNA Medical Directors 95 Hayden Ave

Fresenius Medical Care North America Corporate Headquarters Medical Department To: FMCNA Medical Directors 95 Hayden Ave Fresenius Medical Care North America Corporate Headquarters Medical Department To: FMCNA Medical Directors 95 Hayden Ave Lexington, MA 02420-9192 From: J. Michael Lazarus, M.D. Date: July 5, 2005 Re: Bicarbonate

More information

Sodium elimination and dialysate sodium. How much? Does it matter?

Sodium elimination and dialysate sodium. How much? Does it matter? Sodium elimination and dialysate sodium How much? Does it matter? A. Bock Nephrologie Dialysis visit Aarau 3.12.2013 90 kg dialysis patient: 5 kg over dry weight Recent dyspnea. Minimal leg edema RBV in

More information

Dialysis in frail and Elderly

Dialysis in frail and Elderly Dialysis in frail and Elderly Dr Shibu Jacob, Assistant Professor, Christian Medical College, Vellore. ISHDCON April 2,2017 Complications during dialysis and soon after? How to minimise these? Should

More information

Safe, simple and reliable closed blood sampling for effective patient blood management.9,14

Safe, simple and reliable closed blood sampling for effective patient blood management.9,14 Safe, simple and reliable closed blood sampling for effective patient blood management.9,14 VAMP Systems Venous Arterial Blood Management and Protection Reduce blood loss, hospital-acquired infections,

More information

The kidneys maintain the body s homeostasis by

The kidneys maintain the body s homeostasis by Rationale for Daily Dialysis Umberto Buoncristiani, Riccardo Fagugli, Giuseppe Quintaliani, Hrissanti Kulurianu Nephrology-Dialysis Unit, Ospedale Regionale, Perugia, Italy. The kidneys maintain the body

More information

2019 Home Hemodialysis Standing Orders

2019 Home Hemodialysis Standing Orders 2019 Home Hemodialysis Standing Orders 1. Nutrition Standards of Care: A. Follow P&P Nutrition Standards of Care 2. Laboratory Tests: A. Drawn On Admission: 1. Renal Function Panel (BMP, PO 4 and Albumin)

More information

Hemodialysis is a life-sustaining procedure for the treatment of

Hemodialysis is a life-sustaining procedure for the treatment of The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides

More information

Continuous blood volume monitoring (CBVM) is believed

Continuous blood volume monitoring (CBVM) is believed Continuous Blood Volume Monitoring and Ultrafiltration Control Continuous blood volume monitoring (CBVM) is believed to be a promising method for making the determination of patients dry weight more objective,

More information

Early detection. Proactive intervention.

Early detection. Proactive intervention. Early detection. Proactive intervention. 70% Central Venous Catheter Edwards oximetry central venous catheter (CVC) the first proven CVC with continuous monitoring reveals the true adequacy of tissue oxygenation

More information

86% P(iBP) Hypotension. Clarity

86% P(iBP) Hypotension. Clarity 86% P(iBP) Hypotension Clarity Hypotension Probability Indicator Know before it s low. The Acumen software Hypotension Probability Indicator is a nextgeneration clinical decision support tool that enables

More information

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School

More information

Clinical Policy: Iron Sucrose (Venofer) Reference Number: CP.PHAR.167

Clinical Policy: Iron Sucrose (Venofer) Reference Number: CP.PHAR.167 Clinical Policy: (Venofer) Reference Number: CP.PHAR.167 Effective Date: 03/16 Last Review Date: 03/17 Revision Log Coding Implications See Important Reminder at the end of this policy for important regulatory

More information

Nearly 40 years ago, when dialysis was still in its

Nearly 40 years ago, when dialysis was still in its Dry-Weight: A Concept Revisited in an Effort to Avoid Medication-Directed Approaches for Blood Pressure Control in Hemodialysis Patients Rajiv Agarwal* and Matthew R. Weir *Indiana University School of

More information

CJASN epress. Published on May 27, 2010 as doi: /CJN

CJASN epress. Published on May 27, 2010 as doi: /CJN Original Articles CJASN epress. Published on May 27, 2010 as doi: 10.2215/CJN.01760210 Dry-Weight: A Concept Revisited in an Effort to Avoid Medication-Directed Approaches for Blood Pressure Control in

More information

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

ECMO & Renal Failure Epidemeology Renal failure & effect on out come ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes

More information

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial Hecking et al. Trials 2012, 13:79 TRIALS STUDY PROTOCOL Open Access Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled

More information

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations IV Fluids When administering IV fluids, the type and amount of fluid may influence patient outcomes. Make sure to understand the differences between fluid products and their effects. Crystalloids Crystalloid

More information

IN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient

More information

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate

More information

What is TAVR? Transcatheter Aortic Valve Replacement

What is TAVR? Transcatheter Aortic Valve Replacement What is TAVR? Transcatheter Aortic Valve Replacement What Are Your Options for Treating Severe Aortic Stenosis? Treatment for aortic stenosis depends on how far your disease has progressed. If your stenosis

More information

Assessment of Dry Weight in Hemodialysis: An Overview

Assessment of Dry Weight in Hemodialysis: An Overview REVIEW J Am Soc Nephrol 10: 392 403, 1999 Assessment of Dry Weight in Hemodialysis: An Overview JACK Q. JAEGER and RAVINDRA L. MEHTA Division of Nephrology, Department of Medicine, University of California,

More information

2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home

2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Fluid Management 2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home Objectives Define euvolemia Determine factors which contribute to fluid imbalance Discuss strategies

More information

water & dialysate testing services

water & dialysate testing services water & dialysate testing services Spectra Laboratories, the leading provider of renal-specific testing services, offers clinicians comprehensive water and dialysate testing to help monitor the safety

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.PMN.04 Effective Date: 11.15.17 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Nephros On-line Mid-Dilution Hemodiafiltration System

Nephros On-line Mid-Dilution Hemodiafiltration System _PO Nephros On-line Mid-Dilution Hemodiafiltration System Clinicians Overview with Safety and Efficacy Summary Note: Federal (USA) law restricts these devices to sale by or on the order of a physician.

More information

You can sleep while I dialyze

You can sleep while I dialyze You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep

More information

Achieving Equilibrium in ESRD Patients

Achieving Equilibrium in ESRD Patients Achieving Equilibrium in ESRD Patients -Marc Richards MD -South Florida Kidney Disease and HTN Specialists -Chief of Medicine, BRRH -BRRH Grand Rounds: April 18 th, 2017 Outline Dialysis prescription Adequacy

More information

SENSATION and CS300 Smaller meets faster. IABP System

SENSATION and CS300 Smaller meets faster. IABP System SENSATION and CS300 Smaller meets faster IABP System Cardiac Assist SENSATION and CS300 3 Cardiac Assist SENSATION and CS300 5 Smaller The SENSATION 7Fr. Fiber-Optic IAB Catheter Faster The CS300 with

More information

Device Preparation (all steps to be performed per standard interventional technique)

Device Preparation (all steps to be performed per standard interventional technique) sertera Biopsy Device Instructions for Use Please read all information carefully. Failure to properly follow the instructions may lead to unintended consequences. Important: This package insert is designed

More information

Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: Last Review Date: 02.

Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: Last Review Date: 02. Clinical Policy: Clozapine orally disintegrating tablet (Fazaclo) Reference Number: CP.PMN.12 Effective Date: 08.01.15 Last Review Date: 02.18 Line of Business: Medicaid Revision Log See Important Reminder

More information

Hemodialysis: slightly beyond basics Dialysate calcium and magnesium concentrations

Hemodialysis: slightly beyond basics Dialysate calcium and magnesium concentrations Dialysate calcium and magnesium concentrations Stefan Farese Department of Nephrology Bürgerspital Solothurn 04.12.2013 Dialysate calcium and magnesium concentrations Do we know the optimal concentrations?

More information

61% SvO 2. Clarity. Simplified.

61% SvO 2. Clarity. Simplified. 61% SvO 2 Clarity Simplified. HemoSphere Advanced Monitoring Platform See advanced hemodynamic parameters with a new level* of clarity. The HemoSphere advanced monitoring platform from Edwards Lifesciences

More information

There are no shortcuts to Dialysis

There are no shortcuts to Dialysis There are no shortcuts to Dialysis 1 Outcomes John Sweeny Wednesday, March 21 st, 2018 (3:10 pm 4:10 pm) 2 Quality in Hemodialysis Quality Health Care is the degree to which health services increases the

More information

CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018

CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 CRRT for the Experience User 1 Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018 Disclosures I have no actual or potential conflict of interest

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

Clinical Policy: Ferumoxytol (Feraheme) Reference Number: CP.PHAR.165

Clinical Policy: Ferumoxytol (Feraheme) Reference Number: CP.PHAR.165 Clinical Policy: (Feraheme) Reference Number: CP.PHAR.165 Effective Date: 03/16 Last Review Date: 03/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Haemodialysis. 4008S Visually the best dialysis results

Haemodialysis. 4008S Visually the best dialysis results Haemodialysis 4008S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal replacement

More information

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use The SplitWire Percutaneous Transluminal Angioplasty Scoring Device Instructions for Use Contents Contains one (1) SplitWire device. Sterile. Sterilized with ethylene oxide gas. Radiopaque. For single use

More information

Home Dialysis. Peritoneal Dialysis. Home Hemodialysis

Home Dialysis. Peritoneal Dialysis. Home Hemodialysis Home Dialysis The information provided is not intended to be a substitute for professional medical advice. A licensed healthcare professional should be consulted for diagnosis and treatment of any and

More information

Why NxStage? 4th self-care dialysis symposium 6th & 7th June 2018 Brussels. Page 1

Why NxStage? 4th self-care dialysis symposium 6th & 7th June 2018 Brussels. Page 1 Why NxStage? 4th self-care dialysis symposium 6th & 7th June 2018 Brussels Page 1 Are you prepared? 4.1% Annual increase 1 in European dialysis patients Reference: 1. 2017 USRDS Annual Data Report Reference

More information

Stuart L. Goldstein, MD Recent Improvements in End-Stage Renal Disease Outcome Slide 1

Stuart L. Goldstein, MD Recent Improvements in End-Stage Renal Disease Outcome Slide 1 Slide 1 I d like to say it s really a thrill to actually be able to speak here. And without being indelicate to Drs. Hill, Brewer, Kohaut, Sanjad, and Alexander, I think I m the third generation of pediatric

More information

Clinical Policy: Lofexidine (Lucemyra) Reference Number: ERX.NPA.88 Effective Date:

Clinical Policy: Lofexidine (Lucemyra) Reference Number: ERX.NPA.88 Effective Date: Clinical Policy: (Lucemyra) Reference Number: ERX.NPA.88 Effective Date: 07.31.18 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Efficacy of stepwise sodium profile versus individualized dialysate sodium in blood pressure control among hemodialysis patients

Efficacy of stepwise sodium profile versus individualized dialysate sodium in blood pressure control among hemodialysis patients Original Article Efficacy of stepwise profile versus individualized dialysate in control among hemodialysis patients Nahid Shahgholian 1, Maryam Sadat Hashemi 2, Shahrzade Shahidi 3 ABSTRACT Background:

More information

Capture every aspect of hemodynamic status

Capture every aspect of hemodynamic status Capture every aspect of hemodynamic status Edwards Advanced Technology Swan-Ganz Catheters Hemodynamic Monitoring Systems with Continuous CO, SvO 2, EDV, RVEF, SVR, and SV for Optimal Patient Care The

More information

Daxor BVA-100. Direct Intravascular Blood Volume Analysis

Daxor BVA-100. Direct Intravascular Blood Volume Analysis Daxor BVA-100 Direct Intravascular Blood Volume Analysis Daxor BVA-100 : Introducing a New Standard for Blood Volume Measurement Clinical research has proven that intravascular blood volume measurement

More information

RJ Picciano BA, CHT, OCDT, CHBT Fluid Management Coordinator Centers for Dialysis Care, Cleveland Ohio BONENT President

RJ Picciano BA, CHT, OCDT, CHBT Fluid Management Coordinator Centers for Dialysis Care, Cleveland Ohio BONENT President FLUID MANAGEMENT: WHAT THE NEPHROLOGY TECHNICIAN CAN DO TO HELP? RJ Picciano BA, CHT, OCDT, CHBT Fluid Management Coordinator Centers for Dialysis Care, Cleveland Ohio BONENT President Lori Poole MSN,

More information

Clinical Policy: Ferric Carboxymaltose (Injectafer) Reference Number: CP.PHAR.234

Clinical Policy: Ferric Carboxymaltose (Injectafer) Reference Number: CP.PHAR.234 Clinical Policy: (Injectafer) Reference Number: CP.PHAR.234 Effective Date: 06/16 Last Review Date: 03/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Haemodialysis Machines H/S Visually the best dialysis results

Haemodialysis Machines H/S Visually the best dialysis results Haemodialysis Machines 4008 H/S Visually the best dialysis results Therapy Through continuous optimisation of the treatment modalities Fresenius Medical Care always aims to offer patients the best renal

More information

Intradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia

Intradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy

More information

The next step in dialysis catheter technology

The next step in dialysis catheter technology arrow nextstep retrograde The next step in dialysis catheter technology NEXTSTEP NOW STEP-TIP EASE MEETS SPLIT-TIP FLOW The Arrow NextStep retrograde is the first of its kind, a chronic hemodialysis catheter

More information

LINEAR 7.5Fr. IAB Catheter

LINEAR 7.5Fr. IAB Catheter LINEAR 7.5Fr. IAB Catheter The LINEAR 7.5Fr. Catheter Easier to insert* Proprietary IAB Membrane provides better performance* Abrasion resistance improved 43%* Improved fatigue resistance* Immediate inflation

More information

What you need. When you need it. EV1000 Clinical Platform

What you need. When you need it. EV1000 Clinical Platform What you need. When you need it. EV1000 Clinical Platform EV1000 Clinical Platform The EV1000 clinical platform from Edwards Lifesciences presents the physiologic status of the patient in an intuitive

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Northera) Reference Number: CP.PMN.17 Effective Date: 08.01.16 Last Review Date: 11.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information